Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ZTS · against 78 other Healthcare companies of similar size
Ranked #72 of 79 · scores higher than 9% of peers · safety percentile 9
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)8 peers with a safety percentile of 0–9, including ZTS · Click a bar to see the companies
Mainly because of its debt / equity and beta, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | ZTS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 76 reported | 2.94× | 0.48× | 1% | 33% | |
| BetaLower is better · 76 reported | 0.73 | 0.76 | 53% | 33% | |
| Current ratioHigher is better · 75 reported | 3.08× | 1.80× | 77% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 26.0B USD | 93 | 28 | |
| 2 | 327.3B CNY (≈$45.8B) | 92 | 75 | |
| 3 | 56.7B USD | 85 | 79 | |
| 4 | 8.24T JPY (≈$56.0B) | 83 | 75 | |
| 5 | 25.8B USD | 83 | 75 | |
| 68 | 36.0B USD | 18 | 46 | |
| 69 | 15.8B EUR (≈$17.4B) | 13 | 47 | |
| 70 | 73.2B SAR (≈$19.8B) | 13 | 56 | |
| 71 | 21.4B USD | 12 | 67 | |
| 72 | 34.3B USD | 9 | 57 | |
| 73 | 58.6B USD | 7 | 52 | |
| 74 | 48.9B USD | 5 | 54 | |
| 75 | 272.9B BRL (≈$49.1B) | 5 | 43 | |
| 76 | 23.5B USD | 5 | 27 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score